Exendin-4, a long-acting analogue of GLP-1, can improve hyperglycemic states [7] and can inhibit major complications of diabetes mellitus, such as neuropathy, nephropathy, or retinopathy [25–27]. This evidence concerns the gene GLP1R and retinal disorder.